首页> 外文期刊>Transplant infectious disease: an official journal of the Transplantation Society >Breakthrough Candida guilliermondii Candida guilliermondii ( Meyerozyma guilliermondii Meyerozyma guilliermondii ) fungemia after cord blood transplantation for extranodal NK NK ‐cell lymphoma with azole prophylaxis
【24h】

Breakthrough Candida guilliermondii Candida guilliermondii ( Meyerozyma guilliermondii Meyerozyma guilliermondii ) fungemia after cord blood transplantation for extranodal NK NK ‐cell lymphoma with azole prophylaxis

机译:突破念珠菌念珠菌念珠菌(Meyerozyma Guilliermondii)脐血肠道移植后脐血移植脐血移植与唑类唑类淋巴瘤(Meyerozyma)脐血移植

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Fluconazole ( FLCZ ) is an azole antifungal agent and it has shown excellent clinical activities in suppressing fungemia with Candida albicans after hematopoietic stem cell transplantation. Increased administration of prophylactic FLCZ seems to have given rise to the relatively higher incidence of more resistant Candida non‐albicans infection. We present a case with a rare breakthrough fungemia with C.?guilliermondii after cord blood transplantation for Extranodal NK cell Lymphoma, nasal type ( ENKL ), during antifungal prophylaxis with FLCZ . High level of caution is needed for the breakthrough, especially after long‐term azole administration.
机译:摘要氟康唑(FLCZ)是一种唑氧抗真菌剂,它在造血干细胞移植后用念珠菌醛糖蛋白抑制了抑制功能的优异临床活动。 预防性FLCZ的施用似乎似乎已经引起了更高的抗念珠菌非蛋白酶感染的发生率。 我们展示了一种罕见的突破性诱捕,脐血移植后脐血移植后肠道移植,鼻型(ENKL),抗真预防患有FLCZ。 突破需要高级别的谨慎,特别是在长期唑唑管理后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号